January 16, 2021
ucidevcell

Dewetting: From Physics to the Biology of Intoxicated Cells

Dewetting: From Physics to the Biology of Intoxicated Cells

 Pathogenic micro organism colonize or disseminate into cells and tissues by inducing large-scale remodeling of host membranes. The bodily phenomena underpinning these big membrane extension and deformation are poorly understood. Invasive strategies of pathogens have been simply recently enriched by the define of a spectacular mode of opening of huge transendothelial cell macroaperture (TEM) tunnels correlated to the dissemination of EDIN-producing strains of Staphylococcus aureus by means of a hematogenous route or to the induction of gelatinous edema triggered by the edema toxin from Bacillus anthracis.

Remarkably, these extraordinarily dynamic tunnels shut shortly after they attain a maximal measurement. Opening and closure of TEMs in cells lasts for hours with out inducing endothelial cell demise. Multidisciplinary analysis have started to produce a broader perspective of every the molecular determinants controlling cytoskeleton group at newly curved membranes generated by the opening of TEMs and the bodily processes controlling the dynamics of these tunnels.

Proper right here we speak in regards to the analogy between the opening of TEM tunnels and the bodily concepts of dewetting, stemming from a parallel between membrane stress and ground stress. This analogy provides a broad framework to analysis biophysical constraints in cell membrane dynamics and their diversion by positive invasive microbial brokers

Present advances in myeloid-derived suppressor cell biology

 

In latest occasions, discovering out the place of myeloid-derived suppressor cells (MDSCs) in numerous pathological inflammatory conditions has become a very energetic evaluation area. Although the place of MDSCs in most cancers is relatively successfully established, their place in non-cancerous pathological conditions stays in its infancy resulting in rather a lot confusion. Our targets on this overview are to cope with some present advances in MDSC evaluation in order to lower such confusion and to produce an notion into their function inside the context of various illnesses.

The following issues is perhaps significantly centered upon:

(1) definition and characterization of MDSCs;

(2) whether or not or not all MDSC populations embrace immature cells;

(3) technical factors in MDSC isolation, estimation and characterization;

(4) the origin of MDSCs and their anatomical distribution in effectively being and sickness;

(5) mediators of MDSC development and accumulation;

(6) parts that determine the expansion of 1 MDSC inhabitants over the other;

(7) the Yin and Yang roles of MDSCs. Moreover, the capabilities of MDSCs is perhaps addressed all by the textual content material.

ucidevcell
ucidevcell
NFkB Blocking Peptide
3038BP-50
EUR 153
FADD Blocking Peptide
3039BP-50
EUR 153
PBR Blocking Peptide
3044BP-50
EUR 153
MBD4 Blocking Peptide
3056BP-50
EUR 153
PRMT7 blocking peptide
3059BP-50
EUR 153
DR4 Blocking Peptide
3061BP-50
EUR 153
DR5 Blocking Peptide
3062BP-50
EUR 153
CD40 Blocking Peptide
3072BP-50
EUR 153
Calreticulin Blocking Peptide
3077BP-50
EUR 153
PRMT6 Blocking Peptide
3086BP-50
EUR 153
TCTN1 Blocking Peptide
3087BP-50
EUR 153
TCTN1 Blocking Peptide
3088BP-50
EUR 153
KLF4 Blocking Peptide
3089BP-50
EUR 153
Lin28 Blocking Peptide
3091BP-50
EUR 153
Hsp27 Blocking Peptide
3093BP-50
EUR 153
Hsp60 Blocking Peptide
3094RBP-50
EUR 153
Hsc70 Blocking Peptide
3095BP-50
EUR 153
Hsp70 Blocking Peptide
3097BP-50
EUR 153
SIRT7 Blocking Peptide
3099BP-50
EUR 153
AT2 Blocking Peptide
30R-AA024 100 ug
EUR 241
Description: A synthetic AT2 Blocking peptide for use as a blocking control in assays to test for specificity of AT2 antibody, catalog no. 70R-AR006
UCP3 Blocking Peptide
30R-AU006 100 ug
EUR 241
Description: A synthetic UCP3 Blocking peptide for use as a blocking control in assays to test for specificity of UCP3 antibody, catalog no. 20R-UR003
PKA Blocking Peptide
3115BP-50
EUR 153
Raf1 Blocking Peptide
3116BP-50
EUR 153
Wee1 Blocking Peptide
3120BP-50
EUR 153
Stat1 Blocking Peptide
3133RBP-50
EUR 153
MAK10 Blocking Peptide
3134BP-50
EUR 153
ACADM Blocking Peptide
3137BP-50
EUR 153
ACADL Blocking Peptide
3139BP-50
EUR 153
ACADSB Blocking Peptide
3150BP-50
EUR 153
ACADSB Blocking Peptide
3157BP-50
EUR 153
Survivin Blocking Peptide
3160BP-50
EUR 153
TXNRD1 Blocking Peptide
7005BP-50
EUR 153
EDEM2 Blocking Peptide
6633BP-50
EUR 153
SPHKAP Blocking Peptide
6656BP-50
EUR 153
USP8 Blocking Peptide
6658BP-50
EUR 153
EHHADH Blocking Peptide
6678BP-50
EUR 153
ACTH Blocking Peptide
A1051BP-50
EUR 153
Secretin Blocking Peptide
A1054BP-50
EUR 153
C16orf73 Blocking Peptide
33R-1811 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of C16orf73 antibody, catalog no. 70R-4561
ITGBL1 Blocking Peptide
33R-1812 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ITGBL1 antibody, catalog no. 70R-1700
C6ORF21 Blocking Peptide
33R-1813 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of C6orf21 antibody, catalog no. 70R-1743
PNPLA3 Blocking Peptide
33R-1814 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PNPLA3 antibody, catalog no. 70R-2371
SERPINF2 Blocking Peptide
33R-1815 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SERPINF2 antibody, catalog no. 70R-9700
SLC22A16 Blocking Peptide
33R-1816 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SLC22A16 antibody, catalog no. 70R-1824
MYLIP Blocking Peptide
33R-1817 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of MYLIP antibody, catalog no. 70R-2736
PBEF1 Blocking Peptide
33R-1818 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PBEF1 antibody, catalog no. 70R-1027
WNT9B Blocking Peptide
33R-1820 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of WNT9B antibody, catalog no. 70R-7246
TM4SF4 Blocking Peptide
33R-1822 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TM4SF4 antibody, catalog no. 70R-7470
ZNF550 Blocking Peptide
33R-1823 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF550 antibody, catalog no. 20R-1242
SHROOM2 Blocking Peptide
33R-1824 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SHROOM2 antibody, catalog no. 70R-5079
LOC441964 Blocking Peptide
33R-1825 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of LOC441964 antibody, catalog no. 70R-1024
ADRB1 Blocking Peptide
33R-1826 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ADRB1 antibody, catalog no. 70R-5939
TCP11 Blocking Peptide
33R-1827 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TCP11 antibody, catalog no. 70R-3950
KIF2B Blocking Peptide
33R-1828 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of KIF2B antibody, catalog no. 70R-5498
RBJ Blocking Peptide
33R-1829 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RBJ antibody, catalog no. 70R-5875
MFI2 Blocking Peptide
33R-1830 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of MFI2 antibody, catalog no. 70R-10040
UNC84B Blocking Peptide
33R-1831 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of UNC84B antibody, catalog no. 70R-6991
CLEC4M Blocking Peptide
33R-1832 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CLEC4M antibody, catalog no. 70R-8545
LAYN Blocking Peptide
33R-1833 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of LAYN antibody, catalog no. 70R-7484
FKBP5 Blocking Peptide
33R-1834 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of FKBP5 antibody, catalog no. 70R-2377
GJB6 Blocking Peptide
33R-1835 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GJB6 antibody, catalog no. 70R-6097
FZD5 Blocking Peptide
33R-1836 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of FZD5 antibody, catalog no. 70R-7475
ELMOD1 Blocking Peptide
33R-1837 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ELMOD1 antibody, catalog no. 70R-9490
C9ORF127 Blocking Peptide
33R-1838 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of C9orf127 antibody, catalog no. 70R-7095
KIAA0692 Blocking Peptide
33R-1839 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of KIAA0692 antibody, catalog no. 70R-3254
OR13C5 Blocking Peptide
33R-1840 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of OR13C5 antibody, catalog no. 70R-7901
GINS2 Blocking Peptide
33R-1841 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GINS2 antibody, catalog no. 70R-5625
RGS16 Blocking Peptide
33R-1842 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RGS16 antibody, catalog no. 70R-1260
CACNB2 Blocking Peptide
33R-1843 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CACNB2 antibody, catalog no. 70R-5063
DNER Blocking Peptide
33R-1844 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of DNER antibody, catalog no. 20R-1277
RFPL3 Blocking Peptide
33R-1845 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RFPL3 antibody, catalog no. 70R-1162
PENK Blocking Peptide
33R-1846 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PENK antibody, catalog no. 70R-6226
DGKQ Blocking Peptide
33R-1847 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of DGKQ antibody, catalog no. 70R-9133
NUDC Blocking Peptide
33R-1848 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of NUDC antibody, catalog no. 70R-5520
PABPC5 Blocking Peptide
33R-1849 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PABPC5 antibody, catalog no. 70R-4840
TRAF1 Blocking Peptide
33R-1850 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TRAF1 antibody, catalog no. 70R-10512
ZPLD1 Blocking Peptide
33R-1851 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ZPLD1 antibody, catalog no. 70R-7542
SREBF1 Blocking Peptide
33R-1852 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SREBF1 antibody, catalog no. 70R-10526
ATG4A Blocking Peptide
33R-1853 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ATG4A antibody, catalog no. 70R-2866
KRT14 Blocking Peptide
33R-1854 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of KRT14 antibody, catalog no. 20R-1352
POLDIP3 Blocking Peptide
33R-1855 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of POLDIP3 antibody, catalog no. 70R-4847
SRGAP1 Blocking Peptide
33R-1856 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SRGAP1 antibody, catalog no. 70R-9502
CYLC2 Blocking Peptide
33R-1857 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CYLC2 antibody, catalog no. 70R-2744
DKKL1 Blocking Peptide
33R-1858 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of DKKL1 antibody, catalog no. 70R-7515
CHD1L Blocking Peptide
33R-1859 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CHD1L antibody, catalog no. 70R-1304
MYH9 Blocking Peptide
33R-1860 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of MYH9 antibody, catalog no. 70R-2739
PTTG2 Blocking Peptide
33R-1861 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PTTG2 antibody, catalog no. 70R-8929
NFKBIE Blocking Peptide
33R-1862 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of NFKBIE antibody, catalog no. 70R-8262
TMEM9 Blocking Peptide
33R-1863 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TMEM9 antibody, catalog no. 70R-7412
CAPS Blocking Peptide
33R-1864 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CAPS antibody, catalog no. 70R-5864
RAD54B Blocking Peptide
33R-1865 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of RAD54B antibody, catalog no. 70R-5648
OASL Blocking Peptide
33R-1866 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of OASL antibody, catalog no. 70R-5891
DMAP1 Blocking Peptide
33R-1867 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of DMAP1 antibody, catalog no. 20R-1081
IGFALS Blocking Peptide
33R-1869 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of IGFALS antibody, catalog no. 70R-6072
GPX3 Blocking Peptide
33R-1870 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of GPX3 antibody, catalog no. 70R-5305
THG1L Blocking Peptide
33R-1871 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of THG1L antibody, catalog no. 70R-3535
CCT5 Blocking Peptide
33R-1872 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CCT5 antibody, catalog no. 70R-3888
MBD2 Blocking Peptide
33R-1873 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of MBD2 antibody, catalog no. 70R-1031
KIF2B Blocking Peptide
33R-1874 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of KIF2B antibody, catalog no. 70R-5604
NANOS1 Blocking Peptide
33R-1875 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of NANOS1 antibody, catalog no. 70R-4987
ZNF280C Blocking Peptide
33R-1876 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF280C antibody, catalog no. 70R-8333
Zfp161 Blocking Peptide
33R-1877 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Zfp161 antibody, catalog no. 70R-7991
SSR1 Blocking Peptide
33R-1878 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SSR1 antibody, catalog no. 70R-7311
LOC153222 Blocking Peptide
33R-1879 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of LOC153222 antibody, catalog no. 70R-7905
ASB12 Blocking Peptide
33R-1880 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ASB12 antibody, catalog no. 70R-5841
NID2 Blocking Peptide
33R-1881 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of NID2 antibody, catalog no. 70R-6064
ABCF3 Blocking Peptide
33R-1883 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ABCF3 antibody, catalog no. 70R-6278
SLC5A7 Blocking Peptide
33R-1884 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SLC5A7 antibody, catalog no. 70R-7211
HAO2 Blocking Peptide
33R-1885 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of HAO2 antibody, catalog no. 70R-2913
Katna1 Blocking Peptide
33R-1887 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Katna1 antibody, catalog no. 70R-9162
C6ORF134 Blocking Peptide
33R-1888 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of C6orf134 antibody, catalog no. 70R-3866
CPSF3 Blocking Peptide
33R-1889 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CPSF3 antibody, catalog no. 70R-1351
FBXO3 Blocking Peptide
33R-1890 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of FBXO3 antibody, catalog no. 70R-2790
MPDZ Blocking Peptide
33R-1891 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of MPDZ antibody, catalog no. 70R-2266
ARHGDIG Blocking Peptide
33R-1892 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ARHGDIG antibody, catalog no. 70R-6038
PDXDC1 Blocking Peptide
33R-1893 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of PDXDC1 antibody, catalog no. 70R-4233
LDLRAD1 Blocking Peptide
33R-1894 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of LDLRAD1 antibody, catalog no. 70R-6670
TAF7L Blocking Peptide
33R-1895 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of TAF7L antibody, catalog no. 20R-1157
POLR3GL Blocking Peptide
33R-1896 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of POLR3GL antibody, catalog no. 70R-10078
LDLRAD3 Blocking Peptide
33R-1897 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of LDLRAD3 antibody, catalog no. 70R-9224
ZGPAT Blocking Peptide
33R-1898 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of ZGPAT antibody, catalog no. 70R-3509
Mcm10 Blocking Peptide
33R-1899 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of Mcm10 antibody, catalog no. 70R-8186
HSPA1L Blocking Peptide
33R-1900 100 ug
EUR 180
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of HSPA1L antibody, catalog no. 70R-4431

MRGPRX2 indicators its significance in cutaneous mast cell biology: Does MRGPRX2 be part of mast cells and atopic dermatitis?

 

The invention of MRGPRX2 marks a necessary change in MC biology, explaining non-IgE-mediated scientific phenomena relying on MCs. As receptor for quite a few remedy, MRGPRX2 is important to drug-induced hypersensitivity.

Nonetheless, not solely remedy, however moreover endogenous mediators like neuropeptides and host safety peptides activate MRGPRX2, suggesting its broad affect in cutaneous pathophysiology.

Proper right here, we give a brief overview of MRGPRX2 and its regulation by microenvironmental stimuli, which assist MCs and shall be altered in pores and pores and skin points, and briefly contact on the purposeful packages elicited by MRGPRX2 ligation. Analysis in Mrgprb2-deficient mice (the murine ortholog) help illuminate MRGPRX2’s function in effectively being and sickness.

Present advances on this model assist the long-suspected operational unit between MCs and nerves, with MRGPRX2 being an vital component. Based on the restricted proof for a big contribution of FcεRI/IgE-activated MCs to atopic dermatitis (AD), we develop the hypothesis that MRGPRX2 constitutes the missing hyperlink connecting MCs and AD, a minimum of in chosen endotypes.

Help comes from the multifold changes inside the MC-neuronal system of AD pores and pores and skin (e.g. bigger density of MCs and nearer connections between MCs and nerves, elevated PAR-2/Substance P).

We theorize that these deregulations suffice to impress AD, nonetheless exterior triggers, numerous which activating MRGPRX2 themselves (e.g. Staphylococcus aureus) extra feed into the loop. Itch, most likely probably the most burdensome hallmark of AD, is usually non-histaminergic nonetheless tryptase-dependent, and tryptase is preferentially launched upon MRGPRX2 activation. On account of MRGPRX2 is a very energetic evaluation space, a couple of of the current gaps are susceptible to be closed shortly.

Non-Muscle Myosin II in Axonal Cell Biology: From the Growth Cone to the Axon Preliminary Part

 

By binding to actin filaments, non-muscle myosin II (NMII) generates actomyosin networks that preserve distinctive contractile properties. Their dynamic nature is vital for neuronal biology along with the establishment of polarity, progress cone formation and motility, axon progress all through enchancment (and axon regeneration inside the grownup), radial and longitudinal axonal stress, and synapse formation and efficiency.

On this overview, we speak in regards to the current information on the spatial distribution and efficiency of the actomyosin cytoskeleton in quite a few axonal compartments.

We highlight a couple of of the plain contradictions and open questions inside the space, along with the place of NMII inside the regulation of axon progress and regeneration, the possibility that NMII structural affiliation alongside the axon shaft would possibly administration every radial and longitudinal contractility, and the mechanism and purposeful goal underlying NMII enrichment inside the axon preliminary part.

With the advances in reside cell imaging and super choice microscopy, it is anticipated that inside the near future the spatial distribution of NMII inside the axon, and the mechanisms by which it participates in axonal biology is perhaps extra untangled.

D-Glucuronic acid, free acid

GB0482 5g
EUR 155.16
  • Product category: Biochemicals/Carbohydrates/Sugars

DL-Maleic acid (Toxilic acid)

MA0333 250g
EUR 64.5
  • Product category: Biochemicals/Biological Buffers/Buffer Related

Folic Acid

AG062 1 mg
EUR 523

Ferulic Acid

AG130 1 mg
EUR 523

Benzoic Acid

AG153 1 mg
EUR 523

Trichlorophenoxyacetic Acid

AG169 1 mg
EUR 523

Tenuazonic acid

AG183 1 mg
EUR 523

Glycochenodeoxycholic acid

AG216 1 mg
EUR 523

Arsanilic acid

AG255 1 mg
EUR 523

Gibberellic acid

AG268 1 mg
EUR 523

Ethacrynic Acid

C4125-1000 1 g
EUR 121

Ethacrynic Acid

C4125-10000 10 g
EUR 682

Ethacrynic Acid

C4125-5000 5 g
EUR 383

Asterric Acid

C4549-1 1 mg
EUR 293
Description: IC50: 10 ?M for ET-1 binding to the ETA receptor ofA10 cellsAsterric Acid is an ETA receptor inhibitor. Endothelin (ET), a potent vasoconstrictor/pressor peptide consisting of 21 amino acid residues, was first isolated from the cultures of porcine aortic endothelial cells.

Asterric Acid

C4549-5 5 mg
EUR 963
Description: IC50: 10 ?M for ET-1 binding to the ETA receptor ofA10 cellsAsterric Acid is an ETA receptor inhibitor. Endothelin (ET), a potent vasoconstrictor/pressor peptide consisting of 21 amino acid residues, was first isolated from the cultures of porcine aortic endothelial cells.

Ascorbic Acid

CA052-010 100g
EUR 77

Ascorbic Acid

CA052-050 500g
EUR 131

Maslinic Acid

C4832-10 10 mg
EUR 283
Description: Maslinic acid is a pentacyclic triterpene existed in the protective wax-like coating of the leaves and fruit of Olea europaea L [1]. Maslinic acid is an inhibitor of NO, H2O2, IL-6 and TNF-?.

Maslinic Acid

C4832-25 25 mg
EUR 561
Description: Maslinic acid is a pentacyclic triterpene existed in the protective wax-like coating of the leaves and fruit of Olea europaea L [1]. Maslinic acid is an inhibitor of NO, H2O2, IL-6 and TNF-?.

Maslinic Acid

C4832-5 5 mg
EUR 181
Description: Maslinic acid is a pentacyclic triterpene existed in the protective wax-like coating of the leaves and fruit of Olea europaea L [1]. Maslinic acid is an inhibitor of NO, H2O2, IL-6 and TNF-?.

Fusaric Acid

C5062-250 250 mg
EUR 145
Description: Fusaric acid is a mycotoxin produced by several species of Fusarium [1]. Mycotoxins are biologically active secondary fungal metabolites found as contaminants of food- and feedstuff. Mycotoxin is capable of causing disease and death in both humans and animals.

Fusaric Acid

C5062-500 500 mg
EUR 224
Description: Fusaric acid is a mycotoxin produced by several species of Fusarium [1]. Mycotoxins are biologically active secondary fungal metabolites found as contaminants of food- and feedstuff. Mycotoxin is capable of causing disease and death in both humans and animals.

Tienilic Acid

C5345-10 10 mg
EUR 186
Description: Km: 5 microM for CYP 2C9 catalyzing 5-hydroxylation of tienilic acid Tienilic acid is a specific suicide substrate for CYP2C9 and CYP2C10.Cytochrome P450 enzymes function to metabolize both endogenous and exogenous xenobiotics.

Tienilic Acid

C5345-25 25 mg
EUR 413
Description: Km: 5 microM for CYP 2C9 catalyzing 5-hydroxylation of tienilic acid Tienilic acid is a specific suicide substrate for CYP2C9 and CYP2C10.Cytochrome P450 enzymes function to metabolize both endogenous and exogenous xenobiotics.

Tienilic Acid

C5345-5 5 mg
EUR 131
Description: Km: 5 microM for CYP 2C9 catalyzing 5-hydroxylation of tienilic acid Tienilic acid is a specific suicide substrate for CYP2C9 and CYP2C10.Cytochrome P450 enzymes function to metabolize both endogenous and exogenous xenobiotics.

Tienilic Acid

C5345-50 50 mg
EUR 695
Description: Km: 5 microM for CYP 2C9 catalyzing 5-hydroxylation of tienilic acid Tienilic acid is a specific suicide substrate for CYP2C9 and CYP2C10.Cytochrome P450 enzymes function to metabolize both endogenous and exogenous xenobiotics.

Eicosatetraynoic Acid

C5515-10 10 mg
EUR 158
Description: Eicosatetraynoic Acid is nonspecific inhibitor of cyclooxygenases and lipoxygenases [1]. Cyclooxygenase (COX) is the key enzyme required for the conversion of arachidonic acid to prostaglandins.

Eicosatetraynoic Acid

C5515-25 25 mg
EUR 308
Description: Eicosatetraynoic Acid is nonspecific inhibitor of cyclooxygenases and lipoxygenases [1]. Cyclooxygenase (COX) is the key enzyme required for the conversion of arachidonic acid to prostaglandins.

Eicosatetraynoic Acid

C5515-50 50 mg
EUR 506
Description: Eicosatetraynoic Acid is nonspecific inhibitor of cyclooxygenases and lipoxygenases [1]. Cyclooxygenase (COX) is the key enzyme required for the conversion of arachidonic acid to prostaglandins.

?-Linolenic Acid

C5518-1000 1 g
EUR 261
Description: Gamma-linolenic acid is a weak Leukotriene B4 (LTB4) receptor antagonist.Gamma-linolenic acid (GLA), an omega-6 fatty acid, is an essential fatty acid necessary for human health. You have to get them through food.

?-Linolenic Acid

C5518-250 250 mg
EUR 137
Description: Gamma-linolenic acid is a weak Leukotriene B4 (LTB4) receptor antagonist.Gamma-linolenic acid (GLA), an omega-6 fatty acid, is an essential fatty acid necessary for human health. You have to get them through food.

Evernic Acid

C5610-100 100 mg
EUR 405
Description: Evernic Acid is an inhibitor of two key plasmodial FAS-II enzymes PfFabZ and PfFabIThe Type II fatty acid synthase (FAS) system catalysed fatty acid biosynthesis in most bacteria.

Evernic Acid

C5610-250 250 mg
EUR 760
Description: Evernic Acid is an inhibitor of two key plasmodial FAS-II enzymes PfFabZ and PfFabIThe Type II fatty acid synthase (FAS) system catalysed fatty acid biosynthesis in most bacteria.

Evernic Acid

C5610-50 50 mg
EUR 263
Description: Evernic Acid is an inhibitor of two key plasmodial FAS-II enzymes PfFabZ and PfFabIThe Type II fatty acid synthase (FAS) system catalysed fatty acid biosynthesis in most bacteria.

?-Guanidinoglutaric Acid

C5708-100 100 mg
EUR 458
Description: ?-Guanidinoglutaric Acid is a novel nitric oxide synthase inhibitor with Ki value of 2.69 ?M [1].

?-Guanidinoglutaric Acid

C5708-50 50 mg
EUR 283
Description: ?-Guanidinoglutaric Acid is a novel nitric oxide synthase inhibitor with Ki value of 2.69 ?M [1].

Benzoic Acid

B1676-5.1 10 mM (in 1mL DMSO)
EUR 108
Description: Benzoic acid is a colorless crystalline solid and a simple aromatic carboxylic acid, used as a food preservative.

Benzoic Acid

B1676-50 50 mg
EUR 128
Description: Benzoic acid is a colorless crystalline solid and a simple aromatic carboxylic acid, used as a food preservative.

Clofibric Acid

B1711-5.1 10 mM (in 1mL DMSO)
EUR 108
Description: Clofibric acid is a PPAR? agonist and hypolipidemic agent.

Clofibric Acid

B1711-50 50 mg
EUR 128
Description: Clofibric acid is a PPAR? agonist and hypolipidemic agent.

Flufenamic acid

B1760-100000 100 g
EUR 187
Description: Flufenamic acid

Flufenamic acid

B1760-250000 250 g
EUR 325
Description: Flufenamic acid

Flufenamic acid

B1760-50000 50 g
EUR 125
Description: Flufenamic acid

Tranexamic Acid

B1858-10000 10 g
EUR 142
Description: Tranexamic acid (Transamin) is an antifibrinolytic for blocking lysine-binding sites of plasmin and elastase-derived plasminogen fragments with IC50 of 5 mM.

Tranexamic Acid

B1858-5.1 10 mM (in 1mL DMSO)
EUR 108
Description: Tranexamic acid (Transamin) is an antifibrinolytic for blocking lysine-binding sites of plasmin and elastase-derived plasminogen fragments with IC50 of 5 mM.

Tranexamic Acid

B1858-50 50 mg
EUR 96
Description: Tranexamic acid (Transamin) is an antifibrinolytic for blocking lysine-binding sites of plasmin and elastase-derived plasminogen fragments with IC50 of 5 mM.

Tranexamic Acid

B1858-5000 5 g
EUR 108
Description: Tranexamic acid (Transamin) is an antifibrinolytic for blocking lysine-binding sites of plasmin and elastase-derived plasminogen fragments with IC50 of 5 mM.

Tropodithietic Acid

B1867-1
EUR 251

Oseltamivir Acid

B1886-1
EUR 131

Oseltamivir Acid

B1886-5
EUR 349

Obeticholic Acid

B1898-25
EUR 381

Obeticholic Acid

B1898-5
EUR 142

Chenodeoxycholic Acid

B1908-100 100 mg
EUR 96
Description: Chenodeoxycholic Acid (CDCA), is a hydrophobic primary bile acid that activates nuclear receptors(FXR) involved in cholesterol metabolism.

Chenodeoxycholic Acid

B1908-1000 1 g
EUR 108
Description: Chenodeoxycholic Acid (CDCA), is a hydrophobic primary bile acid that activates nuclear receptors(FXR) involved in cholesterol metabolism.

Chenodeoxycholic Acid

B1908-5.1 10 mM (in 1mL DMSO)
EUR 108
Description: Chenodeoxycholic Acid (CDCA), is a hydrophobic primary bile acid that activates nuclear receptors(FXR) involved in cholesterol metabolism.

Chenodeoxycholic Acid

B1908-5000 5 g
EUR 224
Description: Chenodeoxycholic Acid (CDCA), is a hydrophobic primary bile acid that activates nuclear receptors(FXR) involved in cholesterol metabolism.

Bempedoic acid

B1913-25
EUR 544

Bempedoic acid

B1913-5
EUR 175

Cyclamic acid

B1921-5.1 10 mM (in 1mL DMSO)
EUR 108
Description: Cyclamic acid in the form of its sodium or calcium salt is one of the most widely used artificial sweeteners.

Cyclamic acid

B1921-50 50 mg
EUR 128
Description: Cyclamic acid in the form of its sodium or calcium salt is one of the most widely used artificial sweeteners.

Cyclamic acid

B1921-S Evaluation Sample
EUR 81
Description: Cyclamic acid in the form of its sodium or calcium salt is one of the most widely used artificial sweeteners.

Mycophenolic acid

B1981-5.1 10 mM (in 1mL DMSO)
EUR 108
Description: Mycophenolic acid

Mycophenolic acid

B1981-50 50 mg
EUR 128
Description: Mycophenolic acid

Mycophenolic acid

B1981-S Evaluation Sample
EUR 81
Description: Mycophenolic acid

Nalidixic acid

B1985-5.1 10 mM (in 1mL DMSO)
EUR 108
Description: Nalidixic acid

Nalidixic acid

B1985-50 50 mg
EUR 128
Description: Nalidixic acid

Nalidixic acid

B1985-S Evaluation Sample
EUR 81
Description: Nalidixic acid

Nicotinic Acid

B1987-100000 100 g
EUR 108
Description: Niacin (Vitamin B3) is a water-soluble vitamin and is part of the vitamin B group.

Nicotinic Acid

B1987-5.1 10 mM (in 1mL DMSO)
EUR 108
Description: Niacin (Vitamin B3) is a water-soluble vitamin and is part of the vitamin B group.

Nicotinic Acid

B1987-50 50 mg
EUR 96
Description: Niacin (Vitamin B3) is a water-soluble vitamin and is part of the vitamin B group.

Nicotinic Acid

B1987-500000 500 g
EUR 224
Description: Niacin (Vitamin B3) is a water-soluble vitamin and is part of the vitamin B group.

Aspterric acid

B2233-1
EUR 370

Aspterric acid

B2233-5
EUR 1240

Gibberellic acid

B2234-1G
EUR 120

Gibberellic acid

B2234-5G
EUR 327

Fusidic acid

B2392-100
EUR 120

Fusidic acid

B2392-500
EUR 240

Carglumic acid

B2447-10
EUR 109

Carglumic acid

B2447-50
EUR 229

Eicosapentaenoic Acid

B3464-100 100 mg
EUR 116

Grifolic acid

B5647-.5 500 µg
EUR 142

Grifolic acid

B5647-1 1 mg
EUR 203

Suberohydroxamic Acid

B5976-1000 1 g
EUR 241
Description: Suberohydroxamic Acid (Suberoyl bis-hydroxamic acid, SBHA) is an inhibitor of HDAC with ID50 values of 0.25 and 0.30 ?M for HDAC1 and HDAC3, respectively [1].

Suberohydroxamic Acid

B5976-5.1 10 mM (in 1mL DMSO)
EUR 108
Description: Suberohydroxamic Acid (Suberoyl bis-hydroxamic acid, SBHA) is an inhibitor of HDAC with ID50 values of 0.25 and 0.30 ?M for HDAC1 and HDAC3, respectively [1].

Suberohydroxamic Acid

B5976-500 500 mg
EUR 166
Description: Suberohydroxamic Acid (Suberoyl bis-hydroxamic acid, SBHA) is an inhibitor of HDAC with ID50 values of 0.25 and 0.30 ?M for HDAC1 and HDAC3, respectively [1].

Fenofibric acid

B6128-100 100 mg
EUR 128

Fenofibric acid

B6128-500 500 mg
EUR 290

Oxolinic acid

B6129-10000 10 g
EUR 206
Description: IC50: 4.3 ?M for dopamine uptakeOxolinic acid is a quinolone antibiotic inhibiting bacterial DNA gyrase.DNA gyrase, an enzyme within the class of topoisomerase, relieves strain while double-stranded DNA is being unwound by helicase.

Oxolinic acid

B6129-25000 25 g
EUR 398
Description: IC50: 4.3 ?M for dopamine uptakeOxolinic acid is a quinolone antibiotic inhibiting bacterial DNA gyrase.DNA gyrase, an enzyme within the class of topoisomerase, relieves strain while double-stranded DNA is being unwound by helicase.

Oxolinic acid

B6129-5000 5 g
EUR 137
Description: IC50: 4.3 ?M for dopamine uptakeOxolinic acid is a quinolone antibiotic inhibiting bacterial DNA gyrase.DNA gyrase, an enzyme within the class of topoisomerase, relieves strain while double-stranded DNA is being unwound by helicase.

Lauric Acid

B6155-250000 250 g
EUR 119
Description: Lauric acid, a saturated medium-chain fatty acid with a 12-carbon backbone, is naturally found in various plant and animal fats and oils, which is a major component of palm kernel oil and coconut oil.

Dihydrokainic acid

B6208-1 1 mg
EUR 187

Dihydrokainic acid

B6208-10 10 mg
EUR 334

Dihydrokainic acid

B6208-50 50 mg
EUR 1243

Homoquinolinic acid

B6223-10 10 mg
EUR 357

Homoquinolinic acid

B6223-50 50 mg
EUR 1340

Kainic acid

B6226-1 1 mg
EUR 171
Description: Kainic acid is a selective agonist of kainate receptor [1]. Kainate receptor is an ionotropic receptor that responds to glutamate.

Kainic acid

B6226-10 10 mg
EUR 308
Description: Kainic acid is a selective agonist of kainate receptor [1]. Kainate receptor is an ionotropic receptor that responds to glutamate.

Kainic acid

B6226-50 50 mg
EUR 1136
Description: Kainic acid is a selective agonist of kainate receptor [1]. Kainate receptor is an ionotropic receptor that responds to glutamate.

Kynurenic acid

B6227-5000 5 g
EUR 196

Quinolinic acid

B6228-1000 1 g
EUR 132

Quinolinic acid

B6228-5.1 10 mM (in 1mL DMSO)
EUR 108

(±)-Nipecotic acid

B6231-100 100 mg
EUR 177

Domoic acid

B6241-1 1 mg
EUR 350

Ibotenic acid

B6246-1 1 mg
EUR 115

Ibotenic acid

B6246-25 25 mg
EUR 1276

Ibotenic acid

B6246-5 5 mg
EUR 328

Spaglumic acid

B6288-10 10 mg
EUR 139

Spaglumic acid

B6288-50 50 mg
EUR 231

Cyclopiazonic acid

B6647-10 10 mg
EUR 187

Cyclopiazonic acid

B6647-5 5 mg
EUR 129

(-)-Terreic acid

B6724-10 10 mg
EUR 350
Description: IC50: about 100 ?M for binding of GST-BtkPH to PKC, about 30 ?M for association of Btk with PKCbII, about 10 ?M for JNK1 activity, and about 7 ?M for TNF-a and about 3 ?M for IL-2.

Salicylic acid

B1092-10000 10 g
EUR 119
Description: Salicylic acid is a natural product extract from Willow bark, well known as an antiinflammatory inhibitor of cyclooxygenase activity.

Salicylic acid

B1092-5.1 10 mM (in 1mL DMSO)
EUR 108
Description: Salicylic acid is a natural product extract from Willow bark, well known as an antiinflammatory inhibitor of cyclooxygenase activity.

Salicylic acid

B1092-50000 50 g
EUR 142
Description: Salicylic acid is a natural product extract from Willow bark, well known as an antiinflammatory inhibitor of cyclooxygenase activity.

Orotic acid

B1147-5.1 10 mM (in 1mL DMSO)
EUR 108
Description: Orotic acid (OA) is an intermediate in pyrimidine metabolism.

Orotic acid

B1147-500 500 mg
EUR 108
Description: Orotic acid (OA) is an intermediate in pyrimidine metabolism.

Ellagic Acid

B1154-100
EUR 109

Ellagic Acid

B1154-500
EUR 240

Valproic acid

B1251-10000 10 g
EUR 189
Description: Valproic acid is an inhibitor of HDAC1 with IC50 value of 0.4mM [1].Valproic acid (VPA) is a branched short-chain fatty acid. It is previously synthesized and used as an inert solvent of organic compounds.

Valproic acid

B1251-5.1 10 mM (in 1mL DMSO)
EUR 108
Description: Valproic acid is an inhibitor of HDAC1 with IC50 value of 0.4mM [1].Valproic acid (VPA) is a branched short-chain fatty acid. It is previously synthesized and used as an inert solvent of organic compounds.

Valproic acid

B1251-5000 5 g
EUR 142
Description: Valproic acid is an inhibitor of HDAC1 with IC50 value of 0.4mM [1].Valproic acid (VPA) is a branched short-chain fatty acid. It is previously synthesized and used as an inert solvent of organic compounds.

Mefenamic Acid

B1449-5.1 10 mM (in 1mL DMSO)
EUR 108
Description: Mefenamic acid is a non-steroidal anti-inflammatory agent, which is an inhibitor of cyclooxygenase.Mefenamic acid is a non-steroidal anti-inflammatory drug used to treat pain, including menstrual pain. It is typically prescribed for oral administration. M

Mefenamic Acid

B1449-50 50 mg
EUR 128
Description: Mefenamic acid is a non-steroidal anti-inflammatory agent, which is an inhibitor of cyclooxygenase.Mefenamic acid is a non-steroidal anti-inflammatory drug used to treat pain, including menstrual pain. It is typically prescribed for oral administration. M

Mefenamic Acid

B1449-S Evaluation Sample
EUR 81
Description: Mefenamic acid is a non-steroidal anti-inflammatory agent, which is an inhibitor of cyclooxygenase.Mefenamic acid is a non-steroidal anti-inflammatory drug used to treat pain, including menstrual pain. It is typically prescribed for oral administration. M

Tolfenamic Acid

B1455-5.1 10 mM (in 1mL DMSO)
EUR 108
Description: Tolfenamic acid (TA) is one of the class of non-steroidal anti-inflammatory drugs (NSAIDs).Tolfenamic acid is a NSAID. Tolfenamic acid treatment inhibited cell growth and induced apoptosis as measured by caspase activity and bioelectric impedance. Tolfena

Tolfenamic Acid

B1455-50 50 mg
EUR 102
Description: Tolfenamic acid (TA) is one of the class of non-steroidal anti-inflammatory drugs (NSAIDs).Tolfenamic acid is a NSAID. Tolfenamic acid treatment inhibited cell growth and induced apoptosis as measured by caspase activity and bioelectric impedance. Tolfena

Tolfenamic Acid

B1455-S Evaluation Sample
EUR 81
Description: Tolfenamic acid (TA) is one of the class of non-steroidal anti-inflammatory drugs (NSAIDs).Tolfenamic acid is a NSAID. Tolfenamic acid treatment inhibited cell growth and induced apoptosis as measured by caspase activity and bioelectric impedance. Tolfena

Niflumic acid

B1530-5.1 10 mM (in 1mL DMSO)
EUR 108
Description: Niflumic acid, a Ca2+-activated Cl- channel blocker, is an analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.Niflumic acid, an inhibitor of calcium-activated chloride currents. Niflumic acid does not block directly calciu

Niflumic acid

B1530-50 50 mg
EUR 128
Description: Niflumic acid, a Ca2+-activated Cl- channel blocker, is an analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.Niflumic acid, an inhibitor of calcium-activated chloride currents. Niflumic acid does not block directly calciu

Niflumic acid

B1530-S Evaluation Sample
EUR 81
Description: Niflumic acid, a Ca2+-activated Cl- channel blocker, is an analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.Niflumic acid, an inhibitor of calcium-activated chloride currents. Niflumic acid does not block directly calciu

Obeticholic Acid

B4888-100 100 mg
EUR 595
Description: Obeticholic Acid (6alpha-ethyl-chenodeoxycholic acid, 6-ECDCA, INT-747) is a potent and selective agonist of FXR with EC50 value of 99 nM [1].

Obeticholic Acid

B4888-25 25 mg
EUR 282
Description: Obeticholic Acid (6alpha-ethyl-chenodeoxycholic acid, 6-ECDCA, INT-747) is a potent and selective agonist of FXR with EC50 value of 99 nM [1].

Obeticholic Acid

B4888-5 5 mg
EUR 108
Description: Obeticholic Acid (6alpha-ethyl-chenodeoxycholic acid, 6-ECDCA, INT-747) is a potent and selective agonist of FXR with EC50 value of 99 nM [1].

Obeticholic Acid

B4888-5.1 10 mM (in 1mL DMSO)
EUR 113
Description: Obeticholic Acid (6alpha-ethyl-chenodeoxycholic acid, 6-ECDCA, INT-747) is a potent and selective agonist of FXR with EC50 value of 99 nM [1].

Valerenic acid

B7254-1 1 mg
EUR 268

Citric acid

B7297-500000 500 g
EUR 112

Boric acid

B7305-500000 500 g
EUR 125

Cinnabarinic acid

B7592-10 10 mg
EUR 202

Cinnabarinic acid

B7592-50 50 mg
EUR 732

Xanthurenic acid

B7593-10000 10 g
EUR 537

Xanthurenic acid

B7593-5000 5 g
EUR 311

Folinic acid

B7886-10 10 mg
EUR 108

Folinic acid

B7886-50 50 mg
EUR 166

Glyoxylic acid

B7888-100 100 mg
EUR 108

Glyoxylic acid

B7888-500 500 mg
EUR 166

Folic Acid

AT062 1mg
EUR 945

Ferulic Acid

AT130 1mg
EUR 1790

Benzoic Acid

AT153 1mg
EUR 1368

Trichlorophenoxyacetic Acid

AT169 1mg
EUR 1368

Tenuazonic acid

AT183 1mg
EUR 1114

Glycochenodeoxycholic acid

AT216 1mg
EUR 1114

Arsanilic acid

AT255 1mg
EUR 1368

Gibberellic acid

AT268 1mg
EUR 1368

Itaconic acid

B7891-100 100 mg
EUR 108

Itaconic acid

B7891-500 500 mg
EUR 166

Ketoisovaleric acid

B7892-100 100 mg
EUR 108

Ketoisovaleric acid

B7892-500 500 mg
EUR 166

Lactic acid

B7893-100 100 mg
EUR 108

Lactic acid

B7893-500 500 mg
EUR 166

Malonic acid

B7900-100 100 mg
EUR 108

Leave a Reply

Your email address will not be published. Required fields are marked *